Medical Care
Global Convalescent Plasma Therapy Market Research Report 2025
- Jul 08, 25
- ID: 349017
- Pages: 71
- Figures: 73
- Views: 13
The global market for Convalescent Plasma Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Convalescent Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Convalescent Plasma Therapy.
The Convalescent Plasma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Convalescent Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Convalescent Plasma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft
Segment by Type
IgM
IgG
IgA
Segment by Application
Prophylaxis
Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Convalescent Plasma Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Convalescent plasma is the plasma collected from the recovered or convalesced people consisting of the antibodies against the infection causing microorganism.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Convalescent Plasma Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Convalescent Plasma Therapy.
The Convalescent Plasma Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Convalescent Plasma Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Convalescent Plasma Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bio Farma
Grifols
Hilton Pharma
Biotest
BPL
LFB
Octapharma
CSL Behring
Takeda Pharmaceutical Company Limited
Orthosera Kft
Segment by Type
IgM
IgG
IgA
Segment by Application
Prophylaxis
Treatment
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Convalescent Plasma Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Convalescent Plasma Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.3 Market by Application
1.3.1 Global Convalescent Plasma Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Prophylaxis
1.3.3 Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Convalescent Plasma Therapy Market Perspective (2020-2031)
2.2 Global Convalescent Plasma Therapy Growth Trends by Region
2.2.1 Global Convalescent Plasma Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Convalescent Plasma Therapy Historic Market Size by Region (2020-2025)
2.2.3 Convalescent Plasma Therapy Forecasted Market Size by Region (2026-2031)
2.3 Convalescent Plasma Therapy Market Dynamics
2.3.1 Convalescent Plasma Therapy Industry Trends
2.3.2 Convalescent Plasma Therapy Market Drivers
2.3.3 Convalescent Plasma Therapy Market Challenges
2.3.4 Convalescent Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Convalescent Plasma Therapy Players by Revenue
3.1.1 Global Top Convalescent Plasma Therapy Players by Revenue (2020-2025)
3.1.2 Global Convalescent Plasma Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Convalescent Plasma Therapy Revenue
3.4 Global Convalescent Plasma Therapy Market Concentration Ratio
3.4.1 Global Convalescent Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Convalescent Plasma Therapy Revenue in 2024
3.5 Global Key Players of Convalescent Plasma Therapy Head office and Area Served
3.6 Global Key Players of Convalescent Plasma Therapy, Product and Application
3.7 Global Key Players of Convalescent Plasma Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Convalescent Plasma Therapy Breakdown Data by Type
4.1 Global Convalescent Plasma Therapy Historic Market Size by Type (2020-2025)
4.2 Global Convalescent Plasma Therapy Forecasted Market Size by Type (2026-2031)
5 Convalescent Plasma Therapy Breakdown Data by Application
5.1 Global Convalescent Plasma Therapy Historic Market Size by Application (2020-2025)
5.2 Global Convalescent Plasma Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Convalescent Plasma Therapy Market Size (2020-2031)
6.2 North America Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Convalescent Plasma Therapy Market Size by Country (2020-2025)
6.4 North America Convalescent Plasma Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Convalescent Plasma Therapy Market Size (2020-2031)
7.2 Europe Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Convalescent Plasma Therapy Market Size by Country (2020-2025)
7.4 Europe Convalescent Plasma Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Convalescent Plasma Therapy Market Size (2020-2031)
8.2 Asia-Pacific Convalescent Plasma Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Convalescent Plasma Therapy Market Size (2020-2031)
9.2 Latin America Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Convalescent Plasma Therapy Market Size by Country (2020-2025)
9.4 Latin America Convalescent Plasma Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Convalescent Plasma Therapy Market Size (2020-2031)
10.2 Middle East & Africa Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio Farma
11.1.1 Bio Farma Company Details
11.1.2 Bio Farma Business Overview
11.1.3 Bio Farma Convalescent Plasma Therapy Introduction
11.1.4 Bio Farma Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.1.5 Bio Farma Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Convalescent Plasma Therapy Introduction
11.2.4 Grifols Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Hilton Pharma
11.3.1 Hilton Pharma Company Details
11.3.2 Hilton Pharma Business Overview
11.3.3 Hilton Pharma Convalescent Plasma Therapy Introduction
11.3.4 Hilton Pharma Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.3.5 Hilton Pharma Recent Development
11.4 Biotest
11.4.1 Biotest Company Details
11.4.2 Biotest Business Overview
11.4.3 Biotest Convalescent Plasma Therapy Introduction
11.4.4 Biotest Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.4.5 Biotest Recent Development
11.5 BPL
11.5.1 BPL Company Details
11.5.2 BPL Business Overview
11.5.3 BPL Convalescent Plasma Therapy Introduction
11.5.4 BPL Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.5.5 BPL Recent Development
11.6 LFB
11.6.1 LFB Company Details
11.6.2 LFB Business Overview
11.6.3 LFB Convalescent Plasma Therapy Introduction
11.6.4 LFB Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.6.5 LFB Recent Development
11.7 Octapharma
11.7.1 Octapharma Company Details
11.7.2 Octapharma Business Overview
11.7.3 Octapharma Convalescent Plasma Therapy Introduction
11.7.4 Octapharma Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.7.5 Octapharma Recent Development
11.8 CSL Behring
11.8.1 CSL Behring Company Details
11.8.2 CSL Behring Business Overview
11.8.3 CSL Behring Convalescent Plasma Therapy Introduction
11.8.4 CSL Behring Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.8.5 CSL Behring Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Details
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 Orthosera Kft
11.10.1 Orthosera Kft Company Details
11.10.2 Orthosera Kft Business Overview
11.10.3 Orthosera Kft Convalescent Plasma Therapy Introduction
11.10.4 Orthosera Kft Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.10.5 Orthosera Kft Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Convalescent Plasma Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 IgM
1.2.3 IgG
1.2.4 IgA
1.3 Market by Application
1.3.1 Global Convalescent Plasma Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Prophylaxis
1.3.3 Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Convalescent Plasma Therapy Market Perspective (2020-2031)
2.2 Global Convalescent Plasma Therapy Growth Trends by Region
2.2.1 Global Convalescent Plasma Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Convalescent Plasma Therapy Historic Market Size by Region (2020-2025)
2.2.3 Convalescent Plasma Therapy Forecasted Market Size by Region (2026-2031)
2.3 Convalescent Plasma Therapy Market Dynamics
2.3.1 Convalescent Plasma Therapy Industry Trends
2.3.2 Convalescent Plasma Therapy Market Drivers
2.3.3 Convalescent Plasma Therapy Market Challenges
2.3.4 Convalescent Plasma Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Convalescent Plasma Therapy Players by Revenue
3.1.1 Global Top Convalescent Plasma Therapy Players by Revenue (2020-2025)
3.1.2 Global Convalescent Plasma Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Convalescent Plasma Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Convalescent Plasma Therapy Revenue
3.4 Global Convalescent Plasma Therapy Market Concentration Ratio
3.4.1 Global Convalescent Plasma Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Convalescent Plasma Therapy Revenue in 2024
3.5 Global Key Players of Convalescent Plasma Therapy Head office and Area Served
3.6 Global Key Players of Convalescent Plasma Therapy, Product and Application
3.7 Global Key Players of Convalescent Plasma Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Convalescent Plasma Therapy Breakdown Data by Type
4.1 Global Convalescent Plasma Therapy Historic Market Size by Type (2020-2025)
4.2 Global Convalescent Plasma Therapy Forecasted Market Size by Type (2026-2031)
5 Convalescent Plasma Therapy Breakdown Data by Application
5.1 Global Convalescent Plasma Therapy Historic Market Size by Application (2020-2025)
5.2 Global Convalescent Plasma Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Convalescent Plasma Therapy Market Size (2020-2031)
6.2 North America Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Convalescent Plasma Therapy Market Size by Country (2020-2025)
6.4 North America Convalescent Plasma Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Convalescent Plasma Therapy Market Size (2020-2031)
7.2 Europe Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Convalescent Plasma Therapy Market Size by Country (2020-2025)
7.4 Europe Convalescent Plasma Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Convalescent Plasma Therapy Market Size (2020-2031)
8.2 Asia-Pacific Convalescent Plasma Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Convalescent Plasma Therapy Market Size (2020-2031)
9.2 Latin America Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Convalescent Plasma Therapy Market Size by Country (2020-2025)
9.4 Latin America Convalescent Plasma Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Convalescent Plasma Therapy Market Size (2020-2031)
10.2 Middle East & Africa Convalescent Plasma Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bio Farma
11.1.1 Bio Farma Company Details
11.1.2 Bio Farma Business Overview
11.1.3 Bio Farma Convalescent Plasma Therapy Introduction
11.1.4 Bio Farma Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.1.5 Bio Farma Recent Development
11.2 Grifols
11.2.1 Grifols Company Details
11.2.2 Grifols Business Overview
11.2.3 Grifols Convalescent Plasma Therapy Introduction
11.2.4 Grifols Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.2.5 Grifols Recent Development
11.3 Hilton Pharma
11.3.1 Hilton Pharma Company Details
11.3.2 Hilton Pharma Business Overview
11.3.3 Hilton Pharma Convalescent Plasma Therapy Introduction
11.3.4 Hilton Pharma Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.3.5 Hilton Pharma Recent Development
11.4 Biotest
11.4.1 Biotest Company Details
11.4.2 Biotest Business Overview
11.4.3 Biotest Convalescent Plasma Therapy Introduction
11.4.4 Biotest Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.4.5 Biotest Recent Development
11.5 BPL
11.5.1 BPL Company Details
11.5.2 BPL Business Overview
11.5.3 BPL Convalescent Plasma Therapy Introduction
11.5.4 BPL Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.5.5 BPL Recent Development
11.6 LFB
11.6.1 LFB Company Details
11.6.2 LFB Business Overview
11.6.3 LFB Convalescent Plasma Therapy Introduction
11.6.4 LFB Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.6.5 LFB Recent Development
11.7 Octapharma
11.7.1 Octapharma Company Details
11.7.2 Octapharma Business Overview
11.7.3 Octapharma Convalescent Plasma Therapy Introduction
11.7.4 Octapharma Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.7.5 Octapharma Recent Development
11.8 CSL Behring
11.8.1 CSL Behring Company Details
11.8.2 CSL Behring Business Overview
11.8.3 CSL Behring Convalescent Plasma Therapy Introduction
11.8.4 CSL Behring Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.8.5 CSL Behring Recent Development
11.9 Takeda Pharmaceutical Company Limited
11.9.1 Takeda Pharmaceutical Company Limited Company Details
11.9.2 Takeda Pharmaceutical Company Limited Business Overview
11.9.3 Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Introduction
11.9.4 Takeda Pharmaceutical Company Limited Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.9.5 Takeda Pharmaceutical Company Limited Recent Development
11.10 Orthosera Kft
11.10.1 Orthosera Kft Company Details
11.10.2 Orthosera Kft Business Overview
11.10.3 Orthosera Kft Convalescent Plasma Therapy Introduction
11.10.4 Orthosera Kft Revenue in Convalescent Plasma Therapy Business (2020-2025)
11.10.5 Orthosera Kft Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Convalescent Plasma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of IgM
Table 3. Key Players of IgG
Table 4. Key Players of IgA
Table 5. Global Convalescent Plasma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Convalescent Plasma Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Convalescent Plasma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Convalescent Plasma Therapy Market Share by Region (2020-2025)
Table 9. Global Convalescent Plasma Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Convalescent Plasma Therapy Market Share by Region (2026-2031)
Table 11. Convalescent Plasma Therapy Market Trends
Table 12. Convalescent Plasma Therapy Market Drivers
Table 13. Convalescent Plasma Therapy Market Challenges
Table 14. Convalescent Plasma Therapy Market Restraints
Table 15. Global Convalescent Plasma Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Convalescent Plasma Therapy Market Share by Players (2020-2025)
Table 17. Global Top Convalescent Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2024)
Table 18. Ranking of Global Top Convalescent Plasma Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Convalescent Plasma Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Convalescent Plasma Therapy, Headquarters and Area Served
Table 21. Global Key Players of Convalescent Plasma Therapy, Product and Application
Table 22. Global Key Players of Convalescent Plasma Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Convalescent Plasma Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Convalescent Plasma Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Convalescent Plasma Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Convalescent Plasma Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Convalescent Plasma Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Convalescent Plasma Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Convalescent Plasma Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Convalescent Plasma Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Convalescent Plasma Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bio Farma Company Details
Table 48. Bio Farma Business Overview
Table 49. Bio Farma Convalescent Plasma Therapy Product
Table 50. Bio Farma Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 51. Bio Farma Recent Development
Table 52. Grifols Company Details
Table 53. Grifols Business Overview
Table 54. Grifols Convalescent Plasma Therapy Product
Table 55. Grifols Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 56. Grifols Recent Development
Table 57. Hilton Pharma Company Details
Table 58. Hilton Pharma Business Overview
Table 59. Hilton Pharma Convalescent Plasma Therapy Product
Table 60. Hilton Pharma Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 61. Hilton Pharma Recent Development
Table 62. Biotest Company Details
Table 63. Biotest Business Overview
Table 64. Biotest Convalescent Plasma Therapy Product
Table 65. Biotest Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 66. Biotest Recent Development
Table 67. BPL Company Details
Table 68. BPL Business Overview
Table 69. BPL Convalescent Plasma Therapy Product
Table 70. BPL Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 71. BPL Recent Development
Table 72. LFB Company Details
Table 73. LFB Business Overview
Table 74. LFB Convalescent Plasma Therapy Product
Table 75. LFB Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 76. LFB Recent Development
Table 77. Octapharma Company Details
Table 78. Octapharma Business Overview
Table 79. Octapharma Convalescent Plasma Therapy Product
Table 80. Octapharma Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 81. Octapharma Recent Development
Table 82. CSL Behring Company Details
Table 83. CSL Behring Business Overview
Table 84. CSL Behring Convalescent Plasma Therapy Product
Table 85. CSL Behring Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 86. CSL Behring Recent Development
Table 87. Takeda Pharmaceutical Company Limited Company Details
Table 88. Takeda Pharmaceutical Company Limited Business Overview
Table 89. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product
Table 90. Takeda Pharmaceutical Company Limited Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 91. Takeda Pharmaceutical Company Limited Recent Development
Table 92. Orthosera Kft Company Details
Table 93. Orthosera Kft Business Overview
Table 94. Orthosera Kft Convalescent Plasma Therapy Product
Table 95. Orthosera Kft Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 96. Orthosera Kft Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Convalescent Plasma Therapy Picture
Figure 2. Global Convalescent Plasma Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Convalescent Plasma Therapy Market Share by Type: 2024 VS 2031
Figure 4. IgM Features
Figure 5. IgG Features
Figure 6. IgA Features
Figure 7. Global Convalescent Plasma Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Convalescent Plasma Therapy Market Share by Application: 2024 VS 2031
Figure 9. Prophylaxis Case Studies
Figure 10. Treatment Case Studies
Figure 11. Convalescent Plasma Therapy Report Years Considered
Figure 12. Global Convalescent Plasma Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Convalescent Plasma Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Convalescent Plasma Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Convalescent Plasma Therapy Market Share by Players in 2024
Figure 16. Global Top Convalescent Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Convalescent Plasma Therapy Revenue in 2024
Figure 18. North America Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 20. United States Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 24. Germany Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Convalescent Plasma Therapy Market Share by Region (2020-2031)
Figure 32. China Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bio Farma Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 48. Grifols Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 49. Hilton Pharma Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 50. Biotest Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 51. BPL Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 52. LFB Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 53. Octapharma Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 54. CSL Behring Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 55. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 56. Orthosera Kft Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Table 1. Global Convalescent Plasma Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of IgM
Table 3. Key Players of IgG
Table 4. Key Players of IgA
Table 5. Global Convalescent Plasma Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Convalescent Plasma Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Convalescent Plasma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Convalescent Plasma Therapy Market Share by Region (2020-2025)
Table 9. Global Convalescent Plasma Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Convalescent Plasma Therapy Market Share by Region (2026-2031)
Table 11. Convalescent Plasma Therapy Market Trends
Table 12. Convalescent Plasma Therapy Market Drivers
Table 13. Convalescent Plasma Therapy Market Challenges
Table 14. Convalescent Plasma Therapy Market Restraints
Table 15. Global Convalescent Plasma Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Convalescent Plasma Therapy Market Share by Players (2020-2025)
Table 17. Global Top Convalescent Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2024)
Table 18. Ranking of Global Top Convalescent Plasma Therapy Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Convalescent Plasma Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Convalescent Plasma Therapy, Headquarters and Area Served
Table 21. Global Key Players of Convalescent Plasma Therapy, Product and Application
Table 22. Global Key Players of Convalescent Plasma Therapy, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Convalescent Plasma Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Convalescent Plasma Therapy Revenue Market Share by Type (2020-2025)
Table 26. Global Convalescent Plasma Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Convalescent Plasma Therapy Revenue Market Share by Type (2026-2031)
Table 28. Global Convalescent Plasma Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Convalescent Plasma Therapy Revenue Market Share by Application (2020-2025)
Table 30. Global Convalescent Plasma Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Convalescent Plasma Therapy Revenue Market Share by Application (2026-2031)
Table 32. North America Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Convalescent Plasma Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Convalescent Plasma Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Convalescent Plasma Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Convalescent Plasma Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 47. Bio Farma Company Details
Table 48. Bio Farma Business Overview
Table 49. Bio Farma Convalescent Plasma Therapy Product
Table 50. Bio Farma Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 51. Bio Farma Recent Development
Table 52. Grifols Company Details
Table 53. Grifols Business Overview
Table 54. Grifols Convalescent Plasma Therapy Product
Table 55. Grifols Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 56. Grifols Recent Development
Table 57. Hilton Pharma Company Details
Table 58. Hilton Pharma Business Overview
Table 59. Hilton Pharma Convalescent Plasma Therapy Product
Table 60. Hilton Pharma Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 61. Hilton Pharma Recent Development
Table 62. Biotest Company Details
Table 63. Biotest Business Overview
Table 64. Biotest Convalescent Plasma Therapy Product
Table 65. Biotest Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 66. Biotest Recent Development
Table 67. BPL Company Details
Table 68. BPL Business Overview
Table 69. BPL Convalescent Plasma Therapy Product
Table 70. BPL Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 71. BPL Recent Development
Table 72. LFB Company Details
Table 73. LFB Business Overview
Table 74. LFB Convalescent Plasma Therapy Product
Table 75. LFB Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 76. LFB Recent Development
Table 77. Octapharma Company Details
Table 78. Octapharma Business Overview
Table 79. Octapharma Convalescent Plasma Therapy Product
Table 80. Octapharma Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 81. Octapharma Recent Development
Table 82. CSL Behring Company Details
Table 83. CSL Behring Business Overview
Table 84. CSL Behring Convalescent Plasma Therapy Product
Table 85. CSL Behring Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 86. CSL Behring Recent Development
Table 87. Takeda Pharmaceutical Company Limited Company Details
Table 88. Takeda Pharmaceutical Company Limited Business Overview
Table 89. Takeda Pharmaceutical Company Limited Convalescent Plasma Therapy Product
Table 90. Takeda Pharmaceutical Company Limited Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 91. Takeda Pharmaceutical Company Limited Recent Development
Table 92. Orthosera Kft Company Details
Table 93. Orthosera Kft Business Overview
Table 94. Orthosera Kft Convalescent Plasma Therapy Product
Table 95. Orthosera Kft Revenue in Convalescent Plasma Therapy Business (2020-2025) & (US$ Million)
Table 96. Orthosera Kft Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Convalescent Plasma Therapy Picture
Figure 2. Global Convalescent Plasma Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Convalescent Plasma Therapy Market Share by Type: 2024 VS 2031
Figure 4. IgM Features
Figure 5. IgG Features
Figure 6. IgA Features
Figure 7. Global Convalescent Plasma Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Convalescent Plasma Therapy Market Share by Application: 2024 VS 2031
Figure 9. Prophylaxis Case Studies
Figure 10. Treatment Case Studies
Figure 11. Convalescent Plasma Therapy Report Years Considered
Figure 12. Global Convalescent Plasma Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 13. Global Convalescent Plasma Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Convalescent Plasma Therapy Market Share by Region: 2024 VS 2031
Figure 15. Global Convalescent Plasma Therapy Market Share by Players in 2024
Figure 16. Global Top Convalescent Plasma Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Convalescent Plasma Therapy as of 2024)
Figure 17. The Top 10 and 5 Players Market Share by Convalescent Plasma Therapy Revenue in 2024
Figure 18. North America Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 19. North America Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 20. United States Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. Canada Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Europe Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 24. Germany Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. France Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. U.K. Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Italy Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Russia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Nordic Countries Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Asia-Pacific Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Convalescent Plasma Therapy Market Share by Region (2020-2031)
Figure 32. China Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Japan Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. South Korea Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Southeast Asia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. India Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Australia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Latin America Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 40. Mexico Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Brazil Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Middle East & Africa Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Convalescent Plasma Therapy Market Share by Country (2020-2031)
Figure 44. Turkey Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Saudi Arabia Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. UAE Convalescent Plasma Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Bio Farma Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 48. Grifols Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 49. Hilton Pharma Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 50. Biotest Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 51. BPL Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 52. LFB Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 53. Octapharma Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 54. CSL Behring Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 55. Takeda Pharmaceutical Company Limited Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 56. Orthosera Kft Revenue Growth Rate in Convalescent Plasma Therapy Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global White Oil Market Research Report 2025
Aug 11, 25
Global Piezo Materials Market Research Report 2025
Aug 11, 25
Global Piezoceramic Materials Market Research Report 2025
Aug 11, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232